Track Everything Calories, macros, workouts, measurements
Diabetes (2011) 60(7):191725
Contact your physician if you experience profuse sweating that soaks through clothing, occurs primarily at night (night sweats), or is accompanied by other concerning symptoms such as fever, unexplained weight loss beyond expected treatment effects, chest pain, palpitations, or shortness of breath

Retatrutide (2026) Semaglutide Mechanism: GLP-1 receptor agonist FDA Status: Approved for diabetes and weight management Expected Weight Loss: 1520% body weight Administration: Weekly injection Onset: Appetite changes within first few weeks Cost: Membership pricing at Better Med Spa see plans Tirzepatide Mechanism: Dual GIP + GLP-1 receptor agonist FDA Status: Approved for diabetes and weight management Expected Weight Loss: Up to 22% body weight Administration: Weekly injection Onset: Often faster appetite suppression Cost: Membership pricing at Better Med Spa see plans Retatrutide Mechanism: Triple agonist (GLP-1 + GIP + Glucagon) FDA Status: NOT approved investigational only Expected Weight Loss: Early data suggests very potent effects (up to 24% in trials) Administration: Weekly injection (investigational protocols) Onset: Under investigation Cost: Not yet available What Are Semaglutide, Tirzepatide, and Retatrutide

For Ozempic, count to at least 6 seconds after the dose counter reaches "0" before removing the needle
A company holding a real cost advantage uses it to undercut and take share